8-K Announcements
6Material company update
Jun 10, 2026·SEC
Material company update
May 18, 2026·SEC
Material company update
May 12, 2026·SEC
BIO-key International, Inc.(BKYI)Earnings, Financials & Key Ratios
BKYI•NASDAQ
$4.60
Price updated Jun 27, 2026
AboutBIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.Show more
- Revenue$6M-12.0%
- EBITDA-$4M-9.9%
- Net Income-$5M-6.7%
- EPS (Diluted)-6.91+66.9%
- Gross Margin77.47%-4.8%
- EBITDA Margin-63.7%-24.9%
- Operating Margin-69.89%-20.7%
- Net Margin-75.31%-21.3%
- ROE-80.25%+54.9%
BKYI Price & Volume
BIO-key International, Inc. (BKYI) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operating Losses Undermine Revenue Growth Potential
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity and dilution risk
"BIO-key International faces a challenging fundamental outlook characterized by erratic top-line performance and a persistent inability to achieve operating leverage, as evidenced by consistent net losses over the last ten quarters. While the company maintains high gross margins exceeding 82.5% in 2026Q1, these gains are consistently offset by excessive SG&A and R&D expenditures that exceed gross profit. Investors should remain cautious regarding the company's long-term viability, as the current cash position of $2.2M and ongoing negative free cash flow suggest a high risk of future dilutive capital raises."
Verdict Logic
the company's inability to generate positive free cash flow, coupled with a precarious cash balance of $2.2M against ongoing quarterly losses, suggests significant liquidity and dilution risks for shareholders.
BKYI Growth Metrics
BIO-key International, Inc. (BKYI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years1.48%
5 Years16.53%
3 Years-4.6%
TTM4.37%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM14.67%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM69.42%
Return on Capital
10 Years-106.77%
5 Years-117.15%
3 Years-155.65%
Last Year-72.01%
BKYI Recent Earnings
BIO-key International, Inc. (BKYI) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
May 18, 2026Metric
Actual
Est
EPS
$0.15+75.0%
$0.60
Rev
$2M-2.5%
$2M
Q2 2026
Mar 31, 2026Metric
Actual
Est
EPS
$1.90-171.4%
$0.70
Rev
$1M-43.6%
$2M
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$0.15-25.0%
$0.12
Rev
$2M-13.9%
$2M
Q3 2025
Aug 13, 2025Metric
Actual
Est
EPS
$0.20-33.3%
$0.15
Rev
$2M-0.2%
$2M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 18, 2026 | $0.15vs $0.60+75.0% | $2Mvs $2M-2.5% |
| Q2 2026 | Mar 31, 2026 | $1.90vs $0.70-171.4% | $1Mvs $2M-43.6% |
| Q4 2025 | Nov 14, 2025 | $0.15vs $0.12-25.0% | $2Mvs $2M-13.9% |
| Q3 2025 | Aug 13, 2025 | $0.20vs $0.15-33.3% | $2Mvs $2M-0.2% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for BIO-key International, Inc. (BKYI)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $4.60 | $3.06M | -0.67 | -12.04% | -75.31% | -80.25% | — | |
| $1.48 | $3.45M | -0.55 | 1.85% | -250.66% | -134.07% | — | |
| $2.36 | $259.66K | -0.25 | — | -227.72% | -25.53% | — | |
| $1.10 | $17.75M | -0.80 | 130.2% | -811.67% | -202.13% | — | |
| $7.65 | $2.1B | -57.71 | 17.18% | -21.78% | -26.68% | — | |
| $123.27 | $4.34B | 22.66 | 10.13% | 29.41% | 37.15% | — |
Compare BKYI vs Peers
BIO-key International, Inc. (BKYI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
BKYI SEC Filings & Documents
BIO-key International, Inc. (BKYI) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when BKYI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
BKYI Frequently Asked Questions
BIO-key International, Inc. (BKYI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is BIO-key International, Inc.'s revenue?
BIO-key International, Inc. (BKYI) reported $6.6M in revenue for fiscal year 2025. This represents a 20630% increase from $0.0M in 1996.
How fast is BIO-key International, Inc. growing?
BIO-key International, Inc. (BKYI) saw revenue decline by 12.0% over the past year.
Is BKYI profitable?
BIO-key International, Inc. (BKYI) reported a net loss of $4.0M for fiscal year 2025.
Dividend & Returns
What is BKYI's return on equity?
BIO-key International, Inc. (BKYI) has a return on equity (ROE) of -80.2%. Negative ROE indicates the company is unprofitable.
What is BIO-key International, Inc.'s free cash flow?
BIO-key International, Inc. (BKYI) had negative free cash flow of $4.2M in fiscal year 2025, likely due to heavy capital investments.